HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

BAG6 negatively regulates the RLR signaling pathway by targeting VISA/MAVS.

Abstract
The virus-induced signaling adaptor protein VISA (also known as MAVS, ISP-1, Cardif) is a critical adaptor protein in the innate immune response to RNA virus infection. Upon viral infection, VISA self-aggregates to form a sizeable prion-like complex and recruits downstream signal components for signal transduction. Here, we discover that BAG6 (BCL2-associated athanogene 6, formerly BAT3 or Scythe) is an essential negative regulator in the RIG-I-like receptor signaling pathway. BAG6 inhibits the aggregation of VISA by promoting the K48-linked ubiquitination and specifically attenuates the recruitment of TRAF2 by VISA to inhibit RLR signaling. The aggregation of VISA and the interaction of VISA and TRAF2 are enhanced in BAG6-deficient cell lines after viral infection, resulting in the enhanced transcription level of downstream antiviral genes. Our research shows that BAG6 is a critical regulating factor in RIG-I/VISA-mediated innate immune response by targeting VISA.
AuthorsJing-Ping Huang, Jing Li, Yan-Ping Xiao, Liang-Guo Xu
JournalFrontiers in immunology (Front Immunol) Vol. 13 Pg. 972184 ( 2022) ISSN: 1664-3224 [Electronic] Switzerland
PMID36045679 (Publication Type: Journal Article)
CopyrightCopyright © 2022 Huang, Li, Xiao and Xu.
Chemical References
  • Adaptor Proteins, Signal Transducing
  • BAG6 protein, human
  • Bag6 protein, mouse
  • Molecular Chaperones
  • Nuclear Proteins
  • TNF Receptor-Associated Factor 2
  • VISA protein, mouse
  • Ubiquitin-Protein Ligases
Topics
  • Adaptor Proteins, Signal Transducing (metabolism)
  • Animals
  • Humans
  • Mice
  • Molecular Chaperones (genetics, metabolism)
  • Nuclear Proteins (metabolism)
  • Signal Transduction
  • TNF Receptor-Associated Factor 2 (metabolism)
  • Ubiquitin-Protein Ligases (metabolism)
  • Ubiquitination
  • Virus Diseases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: